AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: LEQEMBI (Eisai / Biogen) (leqembi.com)
A professionally executed pharmaceutical landing site that provides high-quality clinical study parameters but cloaks them in expensive emotional marketing. While the substance is present, the reliance on compensated testimonials and the total lack of modern structured data (Schema) prevents it from achieving a minimal BS score.
Implement Organization and MedicalStudy schema to provide a verifiable digital footprint for the clinical data. Replace the repetitive ‘Time’s Best Inventions’ heading with direct links to the peer-reviewed study results in the New England Journal of Medicine or similar journals. Reduce the reliance on compensated patient testimonials by including real-world evidence (RWE) or post-market surveillance data as it becomes available. Add a specific section naming the scientific leads or medical directors with links to their professional credentials to close the expert authority gap.
The site contains significant substance regarding clinical trial parameters, such as the 18-month study duration and the 1,795-person participant pool (898 in the treatment group, 897 in the control). However, this is balanced against a high volume of fluff in headings like [H1] ‘You Still Can Be’ and [H2] ‘ONE OF TIME’S BEST INVENTIONS’, which function as emotional anchors rather than technical data. The body substance ratio is moderate, providing specific age ranges (50 to 90) and diagnostic criteria (MCI or mild dementia) while frequently reverting to vague marketing phrases like ’embracing every moment’. Repetition of the ‘slowing progression’ value proposition is high across all four audited pages.
Most sites "have schema," but AI still cannot understand what their pages represent. Run a Structured Data AI Audit to see what entity types your pages actually resolve into.
Semantic drift is exceptionally low. The homepage promise of slowing progression for those with MCI or mild dementia due to Alzheimer’s is consistently supported by the sub-pages. The ’18 Months’ page provides the technical transition to maintenance dosing, and the ‘Study Results’ page clarifies that LEQEMBI was ‘not proven to individually impact’ every ability measured, which is a rare instance of high-integrity signal alignment. There is no disconnect between the hero section’s intent and the functional depth of the sub-pages.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
Trust theatre is present primarily through the heavy use of compensated patient testimonials. While the site provides a review_count of 15 on the patient stories page, these are not independent reviews but curated marketing narratives, explicitly stating patients were ‘compensated for their time’. The proof_links_count is 1 per page, typically pointing to the Full Prescribing Information (PI), but there is a lack of direct outbound links to the peer-reviewed publications (e.g., NEJM) in the primary body text. This creates a closed-loop proof environment where the drug manufacturer is the primary source of the evidence presented.
The proof density is high for a commercial site, citing specific study numbers (1,795 people) and tools (Clinical Dementia Rating scale). However, the ratio is diluted by the volume of patient quotes from 10+ named individuals who were compensated, which shifts the weight from scientific proof to anecdotal ‘Patient Stories’. The evidence of ‘maintenance dosing’ is backed by specific FDA-approved schedule changes (once-weekly at-home vs once-monthly infusions), providing concrete substance to the service delivery model.
For a demonstration of entity driven retail architecture, open the Walmart Structured Data audit. View the Walmart Structured Data Audit to see how product, brand, and service entities are reconstructed for AI systems.
The site uses several industry cliches and generic positioning patterns common to high-stakes pharma, such as ‘Get inspired by the LEQEMBI community’ and ‘science-driven solutions’. The value proposition of ‘hope’ and ‘being me’ is a standard trope in dementia treatment marketing. Boilerplate template sections like ‘Start your conversation’ and ‘Connect with a specialist’ are standard for the category and lack unique differentiation in their call-to-action structure. The ‘One of Time’s Best Inventions’ badge is used as a commodity prestige signal across all page headers.
There is a significant technical authority gap due to the total absence of schema_json (null) across all pages, which is unexpected for a top-tier pharmaceutical brand. While the product authority is established by FDA references, there is no structured Person schema for the researchers or medical experts involved in the studies. The technical implementation lacks the structured data footprint necessary to verify expert identities through sameAs links or organizational hierarchy in a machine-readable format.
The marketing tone is highly optimistic (‘You Still Can Be’), which slightly disconnects from the clinical reality of ‘significantly slowing’ rather than reversing or stopping the disease. The site acknowledges this in small print (‘Even though you cannot stop Alzheimer’s…’), but the visual and heading narrative pushes a much stronger performance claim. The use of icons for ‘Remembering’ and ‘Problem-solving’ suggests a broader impact that the text then admits was not individually proven in the study.
Medical Devices, Pharma & Biotech BS: LEQEMBI (Eisai / Biogen) (leqembi.com)
The site perfectly matches the Pharma and Biotech industry, focusing on a specific FDA-approved therapeutic (lecanemab-irmb) for Alzheimer’s disease. It adheres to regulatory requirements including the prominent Boxed Warning and Important Safety Information (ISI).
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The score is primarily driven by Information Density (power words vs specific nouns) and Identity/Authority (lack of schema). The site's near-perfect Semantic Coherence score reflects a very disciplined marketing strategy that avoids contradictory claims, which is typical of highly regulated medical products.”